NCT05555511 is a NA clinical trial of Control Group in Kidney Injury, Acute, sponsored by Ain Shams University.

Who is sponsoring NCT05555511?

NCT05555511 is sponsored by Ain Shams University.

What drugs are being tested in NCT05555511?

Interventions in NCT05555511: Control Group.

What condition does NCT05555511 study?

NCT05555511 studies Kidney Injury, Acute.

Is NCT05555511 still recruiting?

NCT05555511 is currently status unknown. Last updated 28 December 2022.

Last reviewed 2022-12-28 · How we verify

NCT05555511

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Perioperative Use of NAC to Prevent AKI in Patients With Pre-existing Moderate Renal Insufficiency Following Cardiac Surgery

Status unknown NA Last updated 28 December 2022

What this trial tests

NA trial testing Control Group in Kidney Injury, Acute in 46 participants. Status unknown.

Timeline

26 August 2022

Primary endpoint
26 January 2023

26 February 2023

Quick facts

Lead sponsor	Ain Shams University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	46
Start date	26 August 2022
Primary completion	26 January 2023
Estimated completion	26 February 2023
Sites	1 location across Egypt

Drugs / interventions tested

Control Group — full drug profile →

Conditions studied

Kidney Injury, Acute — all drugs for Kidney Injury, Acute →

Sponsor

Ain Shams University

Who can join

18 and older, any sex, with Kidney Injury, Acute. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Acute kidney injury (AKI) or renal impairment is an established complication of cardiac surgery occurring with an incidence up to 30%, To date, no agent has conferred renal protection. Considerable interest has developed in the potential for Nacetylcysteine (NAC) to exert a renoprotective effect in patients undergoing cardiac surgery. Due to the beneficial effect of NAC on contrast nephropathy and its reported anti-inflammatory effects.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Control Group

Trials testing the same drug.

NCT07498556 — Immediate Restoration of a New Implant With High Primary Stability · NA · not yet recruiting
NCT07439289 — Turtle-Assisted Animal Interaction on Dental Anxiety and Physiological Parameters in Children · NA · not yet recruiting
NCT07445711 — Effect of Guided Imagery and AI-Assisted Video on Pain During Uterine Involution Assessment in Postpartum Women: A Rando · NA · not yet recruiting
NCT07418021 — Effects of Cold Spray and Buzzy Device an Pain and Fear During Penicillin Injection · NA · not yet recruiting
NCT07500077 — Strength and Balance Integration in Maintenance Cardiac Rehabilitation for Older Adults · NA · recruiting

Other recruiting trials for Kidney Injury, Acute

Currently open trials in the same condition.

NCT07030166 — A Machine Learning Prediction Model for Postoperative Acute Kidney Injury in Non-Cardiac Surgery Patients · recruiting

Other Ain Shams University trials

Trials by the same sponsor.

NCT07435493 — Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstru · NA · not yet recruiting
NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting
NCT07531030 — Posterior Pericapsular Deep Gluteal Block Combined With Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blo · NA · not yet recruiting
NCT06839027 — Arterial to Central co2gap in Relation to Outcome After Cardiopulmonary Bypass · not yet recruiting
NCT07516535 — DISS vs FANS in Suction-Assisted RIRS for Medium-Sized Renal Stones · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05555511 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ain Shams University
Last refreshed: 28 December 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05555511.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing